These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 968059)

  • 1. N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes.
    Kulkarni PS; Eakins KE
    Prostaglandins; 1976 Sep; 12(3):465-9. PubMed ID: 968059
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Formation of prostaglandin endoperoxides and rabbit aorta contracting substance (RCS) by coupling two enzyme systems.
    Bunting S; Moncada S; Needleman P; Vane JR
    Br J Pharmacol; 1976 Mar; 56(3):344P-345P. PubMed ID: 944058
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition.
    Moncada S; Needleman P; Bunting S; Vane JR
    Prostaglandins; 1976 Sep; 12(3):323-35. PubMed ID: 968048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
    Eakins KE; Kulkarni PS
    Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.
    Needleman P; Moncada S; Bunting S; Vane JR; Hamberg M; Samuelsson B
    Nature; 1976 Jun; 261(5561):558-60. PubMed ID: 934294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazole: a selective inhibitor of thromboxane synthetase.
    Moncada S; Bunting S; Mullane K; Thorogood P; Vane JR; Raz A; Needleman P
    Prostaglandins; 1977 Apr; 13(4):611-8. PubMed ID: 558637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin endoperoxides and thromboxanes: formation and effects.
    Moncada S
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S81-4. PubMed ID: 859657
    [No Abstract]   [Full Text] [Related]  

  • 8. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of endoperoxides and thromboxanes in anaphylactic reactions.
    Hamberg M; Svensson J; Hedqvist P; Strandberg K; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():495-501. PubMed ID: 998440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2.
    Chignard M; Vargaftig BB
    Prostaglandins; 1977 Aug; 14(2):222-40. PubMed ID: 197571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.
    Smith JB; Ingerman C; Silver MJ
    J Clin Invest; 1976 Nov; 58(5):1119-22. PubMed ID: 993335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.
    Ellis EF; Oelz O; Roberts LJ; Payne NA; Sweetman BJ; Nies AS; Oates JA
    Science; 1976 Sep; 193(4258):1135-7. PubMed ID: 959827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the formation and effects of thromboxane A2 in human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1975 Jun; 94(2):222-8. PubMed ID: 1155178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis.
    Higgs GA; Bunting S; Moncada S; Vane JR
    Prostaglandins; 1976 Nov; 12(5):749-57. PubMed ID: 981700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxanes: selective biosynthesis and distinct biological properties.
    Needleman P; Minkes M; Raz A
    Science; 1976 Jul; 193(4248):163-5. PubMed ID: 945611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.
    Charo IF; Feinman RD; Detwiler TC; Smith JB; Ingerman CM; Silver MJ
    Nature; 1977 Sep; 269(5623):66-9. PubMed ID: 895887
    [No Abstract]   [Full Text] [Related]  

  • 18. Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets.
    Nijkamp FP; Moncada S; White HL; Vane JR
    Eur J Pharmacol; 1977 Jul; 44(2):179-86. PubMed ID: 407090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation.
    Samuelsson B; Hamberg M; Malmsten C; Svensson J
    Adv Prostaglandin Thromboxane Res; 1976; 2():737-46. PubMed ID: 983874
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):2994-8. PubMed ID: 1059088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.